查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1972874

主动式伤口护理市场：市场洞察、竞争格局与预测（2033年）

Active Wound Care Market Insights, Competitive Landscape, and Market Forecast - 2033
出版日期: | 出版商: Fairfield Market Research | 英文 196 Pages | 商品交期: 2-5个工作天内

价格
简介目录

全球主动式伤口护理市场预计将稳定成长，2026年达到 28亿美元，2033年达到 38亿美元，年复合成长率（CAGR）为 4.60%。该成长趋势得益于慢性伤口盛行率的上升、对先进伤口癒合解决方案的需求不断成长以及伤口护理技术的持续创新。

市场概览

主动式伤口护理产品目的是透过生物活性机制促进急性和慢性伤口的癒合过程。这些产品包括皮肤替代物、生长因子和生物材料等疗法，能够支持组织再生、预防感染并加速癒合。市场正从传统的伤口管理技术转向能够改善患者预后和生活品质的主动式伤口护理解决方案。

生物工程皮肤替代物和基于生长因子的疗法的最新进展重新定义伤口护理。随着患者意识的提高和医疗机构的广泛应用，主动式伤口护理产品正成为现代伤口管理策略的重要组成部分。人们越来越重视缩短住院时间和减少併发症，这也推动了这些先进解决方案的普及。

市场驱动因素

推动主动式伤口护理市场成长的关键因素有很多。糖尿病、静脉性腿部溃疡和压疮等慢性疾病发生率的上升，使得对先进伤口护理产品的需求显着增加。此外，老年人口的成长（老年人更容易出现癒合延迟的伤口）也促进了市场的持续成长。

技术创新也是一个强大的驱动力，生物工程皮肤替代物、生长因子疗法和生物材料与传统伤口敷料相比，能够实现更快、更有效的癒合。家庭医疗保健和以患者为中心的护理模式的兴起，也为用户友善型先进伤口护理解决方案提供了更多机会。

医疗基础设施的改善，尤其是在新兴地区，支持市场扩张。政府和私人医疗机构对伤口护理计画的投资目的是减轻慢性伤口带来的临床和经济负担。一些已开发国家扩大先进伤口护理疗法的偿付支持，也加速了市场对此疗法的接受度。

市场参与者的机会

伤口护理市场为製造商、投资者和医疗机构提供了多元化的机会。专注于创新疗法的公司，例如生物工程皮肤替代物、生长因子製剂和生物材料，可以充分利用市场对有效且安全的伤口癒合解决方案日益成长的需求。

亚太地区、拉丁美洲以及中东和非洲等新兴市场由于医疗成本上升、病患意识增强以及医疗基础设施改善，蕴藏着巨大的成长潜力。包括远端伤口监测和远距医疗在内的数位医疗解决方案的整合，为产品开发和服务交付开闢新的途径。

生技公司、研究机构和医疗机构之间的合作促进产品的快速商业化。策略性併购也为拓展产品组合、增强区域影响力以及扩大分销网路提供了机会。

区域分析

北美仍然是主动伤口护理领域最大的市场，这主要得益于高额的医疗保健支出、完善的基础设施以及慢性伤口患病率的上升。美国在该市场占据领先地位，这得益于其研发投入和先进伤口护理产品的广泛应用。

欧洲是一个成熟的市场，其特点是创新伤口治疗方法的普及率很高。德国、英国和法国等国家拥有健全的医疗保健和偿付体系，为市场成长做出了显着贡献。

亚太地区崛起为一个高成长地区，这主要得益于人们对先进伤口护理的认识不断提高、患者群体不断成长以及医疗保健投资的增加。中国、日本和印度是该地区市场扩张的重要贡献者。

拉丁美洲以及中东和非洲的市场逐步扩张，这得益于医疗保健基础设施的改善、人们意识的提高以及先进伤口护理解决方案的日益普及。

主要参与者

伤口护理市场的竞争格局包括专注于创新和策略扩张的成熟企业和新兴企业。主要市场参与者包括：

  • Smith & Nephew
  • MiMedx
  • Tissue Regenix
  • Organogenesis Inc.
  • Acell Inc.
  • Integra Life Sciences
  • Solsys Medical
  • Osiris Therapeutics Inc.
  • Cytori Therapeutics Inc.
  • Human BioSciences
  • Wright Medical Group N.V.

这些公司优先考虑研发、联盟和策略合作，以扩展其产品组合、推出先进疗法并加强其区域影响力。

市场区隔

依产品分类：

  • 皮肤替代品
  • 生长因子
  • 生物材料

依自动化程度分类：

  • 慢性伤口
  • 急性伤口

依最终使用者分类：

  • 医院
  • 家庭医疗保健
  • 专科诊所
  • 其他

依地区：

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

目录

第1章 执行概要摘要

第2章 市场概览

  • 市场定义与细分
  • 市场动态
    • 驱动因素
    • 限制因素
    • 市场机会
  • 价值链分析
  • 新冠疫情影响分析
  • 波特五力分析
  • 俄乌衝突的影响
  • PESTLE分析
  • 监理分析
  • 价格趋势分析
    • 当前价格及未来预测（2025-2033年）
    • 价格影响因素

第3章 全球主动伤口照护市场预测（2020-2033年）

  • 全球主动伤口护理市场展望，依产品，价值（十亿美元），2020-2033年
    • 皮肤替代品
    • 生长因子
    • 生物材料
  • 全球主动伤口护理市场预测，依自动化，价值（十亿美元），2020-2033年
    • 慢性伤口
    • 急性伤口
  • 全球主动伤口护理市场预测，依最终用户，价值（十亿美元），2020-2033年
    • 医院
    • 家庭医疗保健
    • 专科诊所
    • 其他
  • 全球主动伤口护理市场预测，依地区，价值（十亿美元），2020-2033年
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲美洲
    • 中东和非洲

第4章 北美主动伤口护理市场展望（2020-2033）

第5章 欧洲主动伤口护理市场展望（2020-2033）

第6章 亚太地区主动伤口照护市场展望（2020-2033）

第7章 拉丁美洲主动伤口护理市场展望（2020-2033）

第8章 中东与非洲主动伤口照护市场展望（2020-2033）

第9章 竞争格局

  • 公司与细分市场热图
  • 公司市场占有率分析2025
  • 竞争格局概览
  • 公司简介
    • Smith & Nephew
    • MiMedx
    • Tissue Regenix
    • Organogenesis Inc.
    • Acell Inc.
    • Integra Life Sciences
    • Solsys Medical
    • Osiris Therapeutics Inc.
    • Cytori Therapeutics Inc.
    • Human BioSciences

第10章 附录

简介目录

The global Active Wound Care Market is expected to experience steady growth, with market value projected at USD 2.8 billion in 2026 and anticipated to reach USD 3.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of 4.60%. The growth trajectory is supported by the increasing prevalence of chronic wounds, rising demand for advanced wound healing solutions, and continuous innovations in wound care technologies.

Market Overview

Active wound care products are designed to accelerate the healing process for both acute and chronic wounds through biologically active mechanisms. This includes therapies such as skin substitutes, growth factors, and biomaterials that support tissue regeneration, prevent infections, and reduce healing time. The market is witnessing a shift from conventional wound management techniques to active wound care solutions that enhance patient outcomes and improve quality of life.

Recent advancements in bioengineered skin substitutes and growth factor-based treatments are redefining the wound care landscape. With rising patient awareness and increased adoption among healthcare providers, active wound care products are becoming integral to modern wound management strategies. The increasing emphasis on reducing hospital stays and minimizing complications is further driving the adoption of these advanced solutions.

Market Drivers

Several key factors are propelling the growth of the active wound care market. The rising incidence of chronic conditions such as diabetes, venous leg ulcers, and pressure injuries has created a significant demand for advanced wound care products. Additionally, the expanding geriatric population, more prone to slow-healing wounds, is contributing to sustained market growth.

Technological innovations remain a strong driver, with bioengineered skin substitutes, growth factor therapies, and biomaterials providing faster, more effective healing compared to traditional wound dressings. The rising trend of home healthcare and patient-centric care models is also expanding opportunities for easy-to-use, advanced wound care solutions.

Healthcare infrastructure improvements, particularly in emerging regions, are supporting market expansion. Investments by governments and private healthcare providers in wound care programs are aimed at lowering the clinical and economic burden associated with chronic wounds. Increased reimbursement support for advanced wound care therapies in several developed countries is another factor accelerating market adoption.

Opportunities for Market Players

The active wound care market presents diverse opportunities for manufacturers, investors, and healthcare providers. Companies focusing on innovative therapies, such as bioengineered skin substitutes, growth factor formulations, and biomaterials, can capitalize on the increasing demand for effective and safe wound healing solutions.

Emerging markets in Asia Pacific, Latin America, and the Middle East & Africa offer substantial growth potential due to rising healthcare expenditures, growing patient awareness, and improving medical infrastructure. Integration of digital healthcare solutions, including remote wound monitoring and telemedicine, is opening new avenues for product development and service delivery.

Collaborations between biotechnology firms, research institutions, and healthcare providers are fostering faster product commercialization. Strategic mergers and acquisitions also provide opportunities to expand product portfolios, enhance regional presence, and strengthen distribution networks.

Regional Analysis

North America remains the largest market for active wound care, driven by high healthcare spending, established infrastructure, and rising chronic wound prevalence. The United States leads the market, supported by research investments and widespread adoption of advanced wound care products.

Europe represents a mature market with high adoption rates for innovative wound therapies. Countries such as Germany, the UK, and France contribute significantly to market growth, supported by strong healthcare systems and reimbursement frameworks.

Asia Pacific is emerging as a high-growth region, fueled by increasing awareness of advanced wound care, growing patient populations, and rising healthcare investments. China, Japan, and India are notable contributors to market expansion in this region.

Latin America and Middle East & Africa are gradually expanding markets, supported by improving healthcare infrastructure, increased awareness, and rising adoption of advanced wound care solutions.

Key Players

The competitive landscape of the active wound care market includes established and emerging companies focused on innovation and strategic expansion. Prominent market players include:

  • Smith & Nephew
  • MiMedx
  • Tissue Regenix
  • Organogenesis Inc.
  • Acell Inc.
  • Integra Life Sciences
  • Solsys Medical
  • Osiris Therapeutics Inc.
  • Cytori Therapeutics Inc.
  • Human BioSciences
  • Wright Medical Group N.V.

These companies prioritize research and development, collaborations, and strategic partnerships to expand their product portfolios, introduce advanced therapies, and enhance regional reach.

Market Segmentation

By Product:

  • Skin Substitutes
  • Growth Factors
  • Biomaterials

By Automation:

  • Chronic Wounds
  • Acute Wounds

By End User:

  • Hospitals
  • Home Healthcare
  • Specialty Clinics
  • Others

By Geographic Coverage:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Active Wound Care Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Active Wound Care Market Outlook, 2020-2033

  • 3.1. Global Active Wound Care Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 3.1.1. Skin Substitutes
    • 3.1.2. Growth Factors
    • 3.1.3. Biomaterials
  • 3.2. Global Active Wound Care Market Outlook, by Automation, Value (US$ Bn), 2020-2033
    • 3.2.1. Chronic Wounds
    • 3.2.2. Acute Wounds
  • 3.3. Global Active Wound Care Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 3.3.1. Hospitals
    • 3.3.2. Home Healthcare
    • 3.3.3. Specialty Clinics
    • 3.3.4. Others
  • 3.4. Global Active Wound Care Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Active Wound Care Market Outlook, 2020-2033

  • 4.1. North America Active Wound Care Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 4.1.1. Skin Substitutes
    • 4.1.2. Growth Factors
    • 4.1.3. Biomaterials
  • 4.2. North America Active Wound Care Market Outlook, by Automation, Value (US$ Bn), 2020-2033
    • 4.2.1. Chronic Wounds
    • 4.2.2. Acute Wounds
  • 4.3. North America Active Wound Care Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 4.3.1. Hospitals
    • 4.3.2. Home Healthcare
    • 4.3.3. Specialty Clinics
    • 4.3.4. Others
  • 4.4. North America Active Wound Care Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Active Wound Care Market Outlook, by Product, 2020-2033
    • 4.4.2. U.S. Active Wound Care Market Outlook, by Automation, 2020-2033
    • 4.4.3. U.S. Active Wound Care Market Outlook, by End User, 2020-2033
    • 4.4.4. Canada Active Wound Care Market Outlook, by Product, 2020-2033
    • 4.4.5. Canada Active Wound Care Market Outlook, by Automation, 2020-2033
    • 4.4.6. Canada Active Wound Care Market Outlook, by End User, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Active Wound Care Market Outlook, 2020-2033

  • 5.1. Europe Active Wound Care Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 5.1.1. Skin Substitutes
    • 5.1.2. Growth Factors
    • 5.1.3. Biomaterials
  • 5.2. Europe Active Wound Care Market Outlook, by Automation, Value (US$ Bn), 2020-2033
    • 5.2.1. Chronic Wounds
    • 5.2.2. Acute Wounds
  • 5.3. Europe Active Wound Care Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 5.3.1. Hospitals
    • 5.3.2. Home Healthcare
    • 5.3.3. Specialty Clinics
    • 5.3.4. Others
  • 5.4. Europe Active Wound Care Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Active Wound Care Market Outlook, by Product, 2020-2033
    • 5.4.2. Germany Active Wound Care Market Outlook, by Automation, 2020-2033
    • 5.4.3. Germany Active Wound Care Market Outlook, by End User, 2020-2033
    • 5.4.4. Italy Active Wound Care Market Outlook, by Product, 2020-2033
    • 5.4.5. Italy Active Wound Care Market Outlook, by Automation, 2020-2033
    • 5.4.6. Italy Active Wound Care Market Outlook, by End User, 2020-2033
    • 5.4.7. France Active Wound Care Market Outlook, by Product, 2020-2033
    • 5.4.8. France Active Wound Care Market Outlook, by Automation, 2020-2033
    • 5.4.9. France Active Wound Care Market Outlook, by End User, 2020-2033
    • 5.4.10. U.K. Active Wound Care Market Outlook, by Product, 2020-2033
    • 5.4.11. U.K. Active Wound Care Market Outlook, by Automation, 2020-2033
    • 5.4.12. U.K. Active Wound Care Market Outlook, by End User, 2020-2033
    • 5.4.13. Spain Active Wound Care Market Outlook, by Product, 2020-2033
    • 5.4.14. Spain Active Wound Care Market Outlook, by Automation, 2020-2033
    • 5.4.15. Spain Active Wound Care Market Outlook, by End User, 2020-2033
    • 5.4.16. Russia Active Wound Care Market Outlook, by Product, 2020-2033
    • 5.4.17. Russia Active Wound Care Market Outlook, by Automation, 2020-2033
    • 5.4.18. Russia Active Wound Care Market Outlook, by End User, 2020-2033
    • 5.4.19. Rest of Europe Active Wound Care Market Outlook, by Product, 2020-2033
    • 5.4.20. Rest of Europe Active Wound Care Market Outlook, by Automation, 2020-2033
    • 5.4.21. Rest of Europe Active Wound Care Market Outlook, by End User, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Active Wound Care Market Outlook, 2020-2033

  • 6.1. Asia Pacific Active Wound Care Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 6.1.1. Skin Substitutes
    • 6.1.2. Growth Factors
    • 6.1.3. Biomaterials
  • 6.2. Asia Pacific Active Wound Care Market Outlook, by Automation, Value (US$ Bn), 2020-2033
    • 6.2.1. Chronic Wounds
    • 6.2.2. Acute Wounds
  • 6.3. Asia Pacific Active Wound Care Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 6.3.1. Hospitals
    • 6.3.2. Home Healthcare
    • 6.3.3. Specialty Clinics
    • 6.3.4. Others
  • 6.4. Asia Pacific Active Wound Care Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Active Wound Care Market Outlook, by Product, 2020-2033
    • 6.4.2. China Active Wound Care Market Outlook, by Automation, 2020-2033
    • 6.4.3. China Active Wound Care Market Outlook, by End User, 2020-2033
    • 6.4.4. Japan Active Wound Care Market Outlook, by Product, 2020-2033
    • 6.4.5. Japan Active Wound Care Market Outlook, by Automation, 2020-2033
    • 6.4.6. Japan Active Wound Care Market Outlook, by End User, 2020-2033
    • 6.4.7. South Korea Active Wound Care Market Outlook, by Product, 2020-2033
    • 6.4.8. South Korea Active Wound Care Market Outlook, by Automation, 2020-2033
    • 6.4.9. South Korea Active Wound Care Market Outlook, by End User, 2020-2033
    • 6.4.10. India Active Wound Care Market Outlook, by Product, 2020-2033
    • 6.4.11. India Active Wound Care Market Outlook, by Automation, 2020-2033
    • 6.4.12. India Active Wound Care Market Outlook, by End User, 2020-2033
    • 6.4.13. Southeast Asia Active Wound Care Market Outlook, by Product, 2020-2033
    • 6.4.14. Southeast Asia Active Wound Care Market Outlook, by Automation, 2020-2033
    • 6.4.15. Southeast Asia Active Wound Care Market Outlook, by End User, 2020-2033
    • 6.4.16. Rest of SAO Active Wound Care Market Outlook, by Product, 2020-2033
    • 6.4.17. Rest of SAO Active Wound Care Market Outlook, by Automation, 2020-2033
    • 6.4.18. Rest of SAO Active Wound Care Market Outlook, by End User, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Active Wound Care Market Outlook, 2020-2033

  • 7.1. Latin America Active Wound Care Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 7.1.1. Skin Substitutes
    • 7.1.2. Growth Factors
    • 7.1.3. Biomaterials
  • 7.2. Latin America Active Wound Care Market Outlook, by Automation, Value (US$ Bn), 2020-2033
    • 7.2.1. Chronic Wounds
    • 7.2.2. Acute Wounds
  • 7.3. Latin America Active Wound Care Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 7.3.1. Hospitals
    • 7.3.2. Home Healthcare
    • 7.3.3. Specialty Clinics
    • 7.3.4. Others
  • 7.4. Latin America Active Wound Care Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Active Wound Care Market Outlook, by Product, 2020-2033
    • 7.4.2. Brazil Active Wound Care Market Outlook, by Automation, 2020-2033
    • 7.4.3. Brazil Active Wound Care Market Outlook, by End User, 2020-2033
    • 7.4.4. Mexico Active Wound Care Market Outlook, by Product, 2020-2033
    • 7.4.5. Mexico Active Wound Care Market Outlook, by Automation, 2020-2033
    • 7.4.6. Mexico Active Wound Care Market Outlook, by End User, 2020-2033
    • 7.4.7. Argentina Active Wound Care Market Outlook, by Product, 2020-2033
    • 7.4.8. Argentina Active Wound Care Market Outlook, by Automation, 2020-2033
    • 7.4.9. Argentina Active Wound Care Market Outlook, by End User, 2020-2033
    • 7.4.10. Rest of LATAM Active Wound Care Market Outlook, by Product, 2020-2033
    • 7.4.11. Rest of LATAM Active Wound Care Market Outlook, by Automation, 2020-2033
    • 7.4.12. Rest of LATAM Active Wound Care Market Outlook, by End User, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Active Wound Care Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Active Wound Care Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 8.1.1. Skin Substitutes
    • 8.1.2. Growth Factors
    • 8.1.3. Biomaterials
  • 8.2. Middle East & Africa Active Wound Care Market Outlook, by Automation, Value (US$ Bn), 2020-2033
    • 8.2.1. Chronic Wounds
    • 8.2.2. Acute Wounds
  • 8.3. Middle East & Africa Active Wound Care Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 8.3.1. Hospitals
    • 8.3.2. Home Healthcare
    • 8.3.3. Specialty Clinics
    • 8.3.4. Others
  • 8.4. Middle East & Africa Active Wound Care Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Active Wound Care Market Outlook, by Product, 2020-2033
    • 8.4.2. GCC Active Wound Care Market Outlook, by Automation, 2020-2033
    • 8.4.3. GCC Active Wound Care Market Outlook, by End User, 2020-2033
    • 8.4.4. South Africa Active Wound Care Market Outlook, by Product, 2020-2033
    • 8.4.5. South Africa Active Wound Care Market Outlook, by Automation, 2020-2033
    • 8.4.6. South Africa Active Wound Care Market Outlook, by End User, 2020-2033
    • 8.4.7. Egypt Active Wound Care Market Outlook, by Product, 2020-2033
    • 8.4.8. Egypt Active Wound Care Market Outlook, by Automation, 2020-2033
    • 8.4.9. Egypt Active Wound Care Market Outlook, by End User, 2020-2033
    • 8.4.10. Nigeria Active Wound Care Market Outlook, by Product, 2020-2033
    • 8.4.11. Nigeria Active Wound Care Market Outlook, by Automation, 2020-2033
    • 8.4.12. Nigeria Active Wound Care Market Outlook, by End User, 2020-2033
    • 8.4.13. Rest of Middle East Active Wound Care Market Outlook, by Product, 2020-2033
    • 8.4.14. Rest of Middle East Active Wound Care Market Outlook, by Automation, 2020-2033
    • 8.4.15. Rest of Middle East Active Wound Care Market Outlook, by End User, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Smith & Nephew
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. MiMedx
    • 9.4.3. Tissue Regenix
    • 9.4.4. Organogenesis Inc.
    • 9.4.5. Acell Inc.
    • 9.4.6. Integra Life Sciences
    • 9.4.7. Solsys Medical
    • 9.4.8. Osiris Therapeutics Inc.
    • 9.4.9. Cytori Therapeutics Inc.
    • 9.4.10. Human BioSciences

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations